ADCT
ADC Therapeutics SACompany with tickers: ADCT
CIK
1771910
CUSIP
H0036K147
Shares Outstanding
127,191,158
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $23,033,000 | USD | 2025-03-31 | 10-Q | 2026-05-04 |
| Revenue (ASC 606) | $17,404,000 | USD | 2025-03-31 | 10-Q | 2026-05-04 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $28,928,000 | USD | 2025-03-31 | 10-Q | 2026-05-04 |
| Operating Income | $-28,464,000 | USD | 2025-03-31 | 10-Q | 2026-05-04 |
| Net Income | $-38,602,000 | USD | 2025-03-31 | 10-Q | 2026-05-04 |
| EPS (Basic) | $-0.36 | USD/shares | 2025-03-31 | 10-Q | 2026-05-04 |
| EPS (Diluted) | $-0.36 | USD/shares | 2025-03-31 | 10-Q | 2026-05-04 |